World of DTC Marketing

APRIL 12, 2021

We need a 21st-century approach that puts patient safety first. In other words, money over safety. Ironically, in later times, the intense competition for out-of-patent drugs has subsided, which has led to spiraling rises in generic drug prices and shortages. Up to 90% of drugs now sold in the US and UK are generic.

Food and Drug Administration 187

Food and Drug Administration Prescription Pharma Manufacturing 187

European Pharmaceutical Review

NOVEMBER 2, 2023

The FDA said its approval of Wezlana is based on “a comprehensive review of scientific evidence demonstrating it is highly similar to Stelara and that there are no clinically meaningful differences between the two products in terms of safety, purity and potency.” Sustainable biosimilar competition in Europe: can it be achieved?

Food and Drug Administration 85

Food and Drug Administration FDA Side effects Safety 85

PM360

NOVEMBER 29, 2022

When developing content for new drug labels, life sciences companies’ regulatory teams face challenges in gathering intelligence to better understand competitive factors, market dynamics, and effective approval strategies. Understanding patient sub-group exceptions for competitive or for label development purposes.

Food and Drug Administration 98

Food and Drug Administration Competition Safety Pharmacology 98

European Pharmaceutical Review

DECEMBER 14, 2023

Over the past few years, we have researched the types of evidence used in regulatory decisions for drug product withdrawals due to safety concerns in Europe. But from a safety point of view, observational studies can be more representative of the population the drug will serve.

Safety 110

Safety Medicine Competition Networking 110

European Pharmaceutical Review

MARCH 8, 2024

As for its benefits in pharmacovigilance, the paper explained that GAMP 5 “helps organisations maintain high-quality standards in adverse event reporting and analysis, ensuring the safety of patients and the integrity of data. GAMP 5 update: computerized system expectations for pharma manufacturers Benefits of Pharma 4.0

Pharmaceutical 80

Pharmaceutical Pharma Safety Manufacturing 80

pharmaphorum

JULY 1, 2022

billion buyout of Principia Biopharma has run into trouble, after the FDA placed it on partial clinical hold while a safety signal is investigated. Those changes haven’t been enough to prevent the FDA from taking action, although outside the US the studies will continue as planned with the tighter safety monitoring.

Side effects 84

Side effects Safety Biopharma Recruitment 84

eMediWrite

JUNE 22, 2023

Your pharmaceutical firm can gain a competitive edge, boost sales, and develop brand loyalty by using effective product positioning. Conduct market research : Market research can be used to determine the client wants that the product can satisfy as well as the competitive environment.

Pharmaceutical products 52

Pharmaceutical products Pharmaceutical Competition Marketing 52

Rep-Lite

MAY 10, 2024

Don’t get it wrong, these are all aimed at ensuring patient safety, transparency, and ethical standards. Collaboration with compliant reps becomes essential in navigating the intricate regulatory environment and safeguarding patient safety and ethical standards within the healthcare ecosystem.

Medical sales 52

Medical sales Sales Medical Medical sales reps 52

Pharmaceutical Technology

OCTOBER 17, 2022

The UK Government has announced funding worth more than $894.6m (£800m) to back research into ground-breaking, experimental therapies and progress the response of the country to patient safety challenges. These research centres comprise a new facility in Exeter.

Safety 52

Safety Government Competition Patients 52

Clarivate

OCTOBER 25, 2021

The move further expands and integrates drug toxicity data and translational safety intelligence from OFF-X into all aspects of the life science cycle. OFF-X is already integrated with several Cortellis products, including Cortellis Drug Discovery Intelligence and Cortellis Competitive Intelligence.

Safety 110

Safety Biopharma Competition Management 110

World of DTC Marketing

JULY 21, 2021

Drug pricing is done by internal teams who look at what the market will bear and the competitive landscape. 3hree: DTC marketing minimizes the side effects of prescription drugs – One of the top pages within prescription drug websites continues to be “safety information.”

Marketing 285

Marketing Prescription Side effects Doctors 285

pharmaphorum

NOVEMBER 16, 2022

Since then, the ophthalmology division has suffered some setbacks, not least the disappointing performance Lucentis follow-up Beovu (brolucizumab), which had been billed as a successor to Lucentis, but has seen its growth pegged back by safety issues. billion in the first nine months of this year.

Sales 119

Sales Prescription Medicine Media 119

Clarivate

JULY 31, 2023

The migration of these products and services into the Clarivate portfolio further bolster solutions that support pharmacovigilance medical literature monitoring, patent research, systematic review literature searches, MDR literature review searches, as well as competitive and business intelligence research.

Healthcare 52

Healthcare Healthcare Safety Competition 52

Pharmaceutical Technology

FEBRUARY 24, 2023

The revision process is reviving old conflicts in the pharma industry over fair and affordable access to medicines versus Europe’s status as a competitive home for pharma innovation. EU competitiveness Moll said the legislation revisions should instead be used to make Europe more attractive to pharma companies.

Pharma 64

Pharma Medicine Competition Food 64

Pharmaceutical Technology

DECEMBER 5, 2022

Overall, Aurinia’s Lupkynis is expected to face tough competition from Benlysta in LN, which received FDA approval in December 2020 and EMA approval in May 2021. Key opinion leaders (KOLs) interviewed by GlobalData believe this may have significant impact on patients as the less-invasive route of administration will be preferred by many.

Food and Drug Administration 59

Food and Drug Administration Physicians Competition FDA 59

Pharmaceutical Technology

JANUARY 23, 2023

The management of SLE and LN consists largely of treatment options that are based on highly efficacious steroids or immune-suppressive therapy with an undesirable safety profile, which includes accrued organ damage, infections and cancer.

Marketing 111

Marketing Safety Patients Pharmaceutical 111

Pharmaceutical Technology

APRIL 20, 2023

Maxion Therapeutics announced it has been awarded a £2m ($2.5m) grant from Innovate UK as part of a biomedical R&D funding competition. Antibody-based therapies provide enhanced efficacy and safety whilst reducing the need for frequent administration for autoimmune disease treatment.

Engineering 52

Engineering Competition Safety Leads 52

Pharmaceutical Technology

APRIL 20, 2023

“Medidata’s solutions will enable us to enhance clinical trials and research timelines and strengthen our competitive advantage globally.” The latest partnership comes shortly after Launch Therapeutics selected Medidata’s AI Intelligent Trials solution for improved clinical trials capability.

Distribution 52

Distribution Management Competition Safety 52

Pharmaceutical Technology

JUNE 14, 2023

It acts as a competitive decoy for bacterial virulence factors that contribute to complications, sepsis, septic shock and death following infection. The therapy comprises liposomes engineered to capture the virulence factors, which are produced by a wide range of Gram-positive and Gram-negative bacteria.

Food and Drug Administration 52

Food and Drug Administration FDA Engineering Food 52

Pharmaceutical Technology

DECEMBER 22, 2022

Increased trafficking of illegal fentanyl represents a new threat to public health and safety. Fentanyl’s addictive properties mean that a) a consumer’s addiction will overpower any safety concerns they may have, and b) the drug can secure more addicts than it kills. A lethal drug that creates its own demand. A dangerous future.

Safety 105

Safety Manufacturing Distribution Prescription 105

pharmaphorum

OCTOBER 4, 2022

Recently Novo Nordisk’s rival Lilly won out in a head-to-head trial competition with its Mounjaro, in comparison to Novo Nordisk’s Ozempic, as an add-on treatment for type 2 diabetes. ONWARDS 6 is to assess the efficacy and safety of insulin icodec in 583 people with type 1 diabetes.

Safety 57

Safety Competition Patients 57

Pharmaceutical Technology

MARCH 24, 2023

Biosimilars are an important tool to facilitate competition, lower the price of drugs, and create savings across the board. Further, there remains scepticism on the efficacy and safety of biosimilars. At the current rate, biosimilars have not yet achieved the intended goal of increasing competition and reducing prices.

Competition 59

Competition Marketing FDA Physicians 59

Pharmaceutical Technology

FEBRUARY 23, 2023

InDex reported that cobitolimod has very limited systemic absorption and an excellent safety profile, in sharp contrast to many approved therapies such as Pfizer’s Xeljanz (tofacitinib). The post New pipeline agents expected to differentiate the UC market appeared first on Pharmaceutical Technology.

Marketing 59

Marketing Safety Competition Pharmaceutical 59

pharmaphorum

JANUARY 3, 2023

Side-effect data from the open-label studies was also encouraging, helping to downplay concerns abut evenamide’s cardiovascular and central nervous system safety that emerged in 2019. ” The new data could accelerate partnering efforts of the drug this year.

Side effects 103

Side effects Biopharma Patients Competition 103

Pharmaceutical Technology

JANUARY 27, 2023

While clinical data shows good efficacy and safety of Briumvi, the agent will probably face a hard time on the MS market, as most KOLs would not consider switching their existing patients to it, unless their patients were intolerant to another anti-CD20 treatment. All three treatments are monoclonal antibodies.

Marketing 52

Marketing Side effects Safety Specialization 52

Pharmaceutical Technology

AUGUST 5, 2022

With respect to its safety profile, Cimerli had more than 3% fewer adverse events (AEs) than Lucentis; however, there were no clinically relevant differences for safety. Thus, the biosimilar presented a similar efficacy to the reference product.

Food and Drug Administration 52

Food and Drug Administration FDA Safety Insurance 52

Contrarian Sales Techniques

JANUARY 27, 2023

It can be challenging when you find yourself promoting products that seem to contradict each other, as it can raise questions about the effectiveness and safety of the products you're selling. One of the biggest challenges faced by sales representatives today is the increasing competition in the market.

Sales 52

Sales Side effects Education Ethics 52

European Pharmaceutical Review

MAY 22, 2023

Key concerns for participants include safety and health, the time and effort required and a lack of job flexibility. Carried out online in 2022, 1,049 people responded to the survey. The results identified financial payment as the most popular motivation for taking part in clinical studies.

Recruitment 81

Recruitment Pharmaceutical Competition Safety 81

European Pharmaceutical Review

OCTOBER 27, 2023

Benefits of The Future Clinical Trials Bill Chiefly, the Bill’s goal is to increase patient participation and overall, ensure clinical trials have the highest levels of safety while enabling greater regulatory pragmatism, the author explained. If achieved, this would boost the UK’s competitiveness as a leading international site for trials.

Ethics 83

Ethics Medicine Education Competition 83

pharmaphorum

AUGUST 24, 2022

Indivior has failed in its bid to prevent a lawsuit claiming that it illegally blocked competition to opioid addiction drug Suboxone from coming to court in the US. Indivior made an application for a judgment in its favour without coming to trial, but that has been denied by Judge Mitchell Goldberg in a Philadelphia court. .

Competition 52

Competition Marketing Healthcare Healthcare 52

European Pharmaceutical Review

DECEMBER 19, 2022

3 Under this pathway, comparability studies are required to substantiate the similar nature, in terms of safety and efficacy, of the biosimilar and the reference product. The Impact of Biosimilar Competition in Europe, IQVIA, December 2021. EMA Guideline on Similar Biological Medicinal Products, 23 October 2014, CHMP/437/04 Rev 1.

Medicine 52

Medicine Biopharma Safety Food 52

Clarivate

OCTOBER 19, 2023

Drug candidates have a high rate of failure, as only 10% of de-novo drugs put through clinical trials finally obtain market approval, with the highest rate of attrition occurring at phase I and II of clinical trials (assessing safety, tolerability, dosage, efficacy, and side effects).

Networking 59

Networking Consulting Safety Side effects 59

PM360

SEPTEMBER 21, 2023

Attention deficit hyperactivity disorder (ADHD) drug Vyvanse (lisdexamfetamine dimesylate) , manufactured by Takeda, also is facing generic competition. In the respiratory area with inhalers, it’s tough to get drugs approved, so the competition comes slowly,” he said.

Management 105

Management Manufacturing Sales Competition 105

European Pharmaceutical Review

DECEMBER 4, 2023

Simultaneously, there is increasing need for stringent quality control and traceability throughout the supply chain to ensure patient safety. These insights help to drive highly efficient manufacturing processes, ensuring competitive product delivery on time and within budget. principles.

Pharmaceutical manufacturing 87

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharmaceutical products 87

Pharma Marketing Network

APRIL 1, 2023

With a focus on marketing and digital health, Pharma-Mkting.com provides a wealth of information, resources, and insights to help these industries succeed in an increasingly competitive market. One of the key areas of expertise for Pharma-Mkting.com is pharmaceutical marketing.

Pharma 52

Pharma Medical Pharmaceutical Marketing 52

Pharmaceutical Technology

OCTOBER 6, 2022

In order to plug the gap between demand and capacity and win back their competitive advantage, many pharmaceutical and fine chemical companies are turning to pre-engineered, end-to end providers to fulfil their API demand. Worker safety. These turnkey solutions cover every process through the drug manufacturing life cycle.

Pharmaceutical 52

Pharmaceutical Engineering Transportation Safety 52

pharmaphorum

NOVEMBER 25, 2022

Alberto Chiesi also remarked that the industry is grappling with growing global competition, in which Europe is losing ground in R&D: 48% of new products globally are developed in the United States, compared with 25% in Europe. Going beyond the standards of care; improving drug safety and efficacy.

Pharmaceutical 94

Pharmaceutical Manufacturing Medicine Competition 94